Conversely, gain-of-function through increased KCC3 expression correlates with enhanced aggressiveness and invasiveness of human malignancies, including cervical, breast, ovarian cancers and astrocytomas [7]–[12]. Here, SLC12A6 is linked to ovarian cancer.